Dr Elliot Frohman : Multiple Sclerosis Biomarkers and Applications

Elliot Frohman, MD, PhD, FANA, FAAN

Senior Distinguished Fellow (Sabbatical) at Laboratory of Neuroimmunology of Professor Lawrence Steinman, at the Stanford University School of Medicine

Elliot Frohman is the former Inaugural Director of the Multiple Sclerosis & Neuroimmunology Center, at the new Dell Medical School at the University of Texas at Austin from May 2017 till June of 2020. He was the Founding Director (1995‐2016) of the MS and Neuroimmunology Program, and the Clinical Center for MS in the Department of Neurology and Neurotherapeutics at the University of Texas Southwestern Medical Center in Dallas. Since his arrival at UT Southwestern in 1995, Elliot along with his wife and principal collaborator Teresa Frohman (they have co‐authored over 100 peer‐review manuscripts) built one of the largest and most significant MS centers anywhere.

Dr. Frohman was born in New York City and received his undergraduate training in biochemistry and cell biology at the University of California at San Diego, and later completed the Physician Scientist Training Program for his MD and PhD degrees at the University of California at Irvine. Dr. Frohman subsequently completed his residency and fellowship training in the Department of Neurology at the Johns Hopkins University School of Medicine and the Johns Hopkins Hospital (1991‐1995), where he also served as Chief Resident from 1993‐1994. Dr. Frohman has published over 300 peer‐review articles, book chapters and monographs, and serves as a principal investigator on a number of MS clinical trials.

Dr. Frohman, in conjunction with his two closest research colleagues for more than 15 years, Dr. Peter Calabresi (Director, MS Program at Johns Hopkins) and Dr. Laura Balcer (Head of Neuro‐Ophthalmology and Vice Chair of Neurology at NYU), were awarded the 2015 National Multiple Sclerosis Society Barancik Prize for Innovation in MS Research (considered to be the most prestigious research award in the MS field). “The ‘trio’ have been focused on the construct that the eye can be utilized as a ‘window’ into the central nervous system of neurodegenerative disorders for both elucidating mechanisms of disease, but also for the identification and monitoring of protective, performance enhancing, preventative, and even restorative properties of novel neurotherapeutic agents. In 2017, Dr. Frohman was among 16 worldwide elected to the Johns Hopkins Society of Scholars which recognizes former Johns Hopkins trainees who have made significant contributions to patient care, education, and discovery at other institutions. Dr. Frohman and Teresa have four children.